These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25819018)

  • 1. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.
    Boyman O; Kaegi C; Akdis M; Bavbek S; Bossios A; Chatzipetrou A; Eiwegger T; Firinu D; Harr T; Knol E; Matucci A; Palomares O; Schmidt-Weber C; Simon HU; Steiner UC; Vultaggio A; Akdis CA; Spertini F
    Allergy; 2015 Jul; 70(7):727-54. PubMed ID: 25819018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Biologicals for the Treatment of Allergic Diseases and Asthma.
    Tan HT; Sugita K; Akdis CA
    Curr Allergy Asthma Rep; 2016 Oct; 16(10):70. PubMed ID: 27613653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances and novel developments in mechanisms of allergic inflammation.
    Han X; Krempski JW; Nadeau K
    Allergy; 2020 Dec; 75(12):3100-3111. PubMed ID: 33068299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-allergic activity of R-phycocyanin from Porphyra haitanensis in antigen-sensitized mice and mast cells.
    Liu Q; Wang Y; Cao M; Pan T; Yang Y; Mao H; Sun L; Liu G
    Int Immunopharmacol; 2015 Apr; 25(2):465-73. PubMed ID: 25746371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor necrosis factor-alpha treatment reduces allergic responses in an allergic rhinitis mouse model.
    Mo JH; Kang EK; Quan SH; Rhee CS; Lee CH; Kim DY
    Allergy; 2011 Feb; 66(2):279-86. PubMed ID: 21208219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
    Fajt ML; Wenzel SE
    J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptanthrin inhibits Th2 development, and IgE-mediated degranulation and IL-4 production by rat basophilic leukemia RBL-2H3 cells.
    Iwaki K; Ohashi E; Arai N; Kohno K; Ushio S; Taniguchi M; Fukuda S
    J Ethnopharmacol; 2011 Mar; 134(2):450-9. PubMed ID: 21216280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
    Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
    Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New biologics for allergic diseases.
    Manka LA; Wechsler ME
    Expert Rev Clin Immunol; 2018 Apr; 14(4):285-296. PubMed ID: 29611440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor.
    Molfino NA; Gossage D; Kolbeck R; Parker JM; Geba GP
    Clin Exp Allergy; 2012 May; 42(5):712-37. PubMed ID: 22092535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 and Allergy.
    Nambu A; Nakae S
    Allergol Int; 2010 Jun; 59(2):125-35. PubMed ID: 20414049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and clinical impact of anti-allergy agents: An overview.
    Kapoor Y; Kumar K
    Bioorg Chem; 2020 Jan; 94():103351. PubMed ID: 31668464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologics in Children with Allergic Diseases.
    Licari A; Manti S; Marseglia A; De Filippo M; De Sando E; Foiadelli T; Marseglia GL
    Curr Pediatr Rev; 2020; 16(2):140-147. PubMed ID: 31660839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization.
    Chu DK; Llop-Guevara A; Walker TD; Flader K; Goncharova S; Boudreau JE; Moore CL; Seunghyun In T; Waserman S; Coyle AJ; Kolbeck R; Humbles AA; Jordana M
    J Allergy Clin Immunol; 2013 Jan; 131(1):187-200.e1-8. PubMed ID: 23006545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological approaches.
    Avila PC; Kishiyama JL; Adelman DC
    Clin Allergy Immunol; 2002; 16():469-94. PubMed ID: 11577555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease.
    Mitchell J; Dimov V; Townley RG
    Curr Opin Investig Drugs; 2010 May; 11(5):527-34. PubMed ID: 20419598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual cytokines contributing to asthma pathophysiology: valid targets for asthma therapy?
    Chung KF
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1320-6. PubMed ID: 14758771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Catalpa ovata stem bark on atopic dermatitis-like skin lesions in NC/Nga mice.
    Yang G; Choi CH; Lee K; Lee M; Ham I; Choi HY
    J Ethnopharmacol; 2013 Jan; 145(2):416-23. PubMed ID: 23195129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.